191 related articles for article (PubMed ID: 28544138)
1. Inhibition of the Aggregation and Toxicity of the Minimal Amyloidogenic Fragment of Tau by Its Pro-Substituted Analogues.
Chemerovski-Glikman M; Frenkel-Pinter M; Mdah R; Abu-Mokh A; Gazit E; Segal D
Chemistry; 2017 Jul; 23(40):9618-9624. PubMed ID: 28544138
[TBL] [Abstract][Full Text] [Related]
2. Integrating in vitro and in silico approaches to evaluate the "dual functionality" of palmatine chloride in inhibiting and disassembling Tau-derived VQIVYK peptide fibrils.
Haj E; Losev Y; Guru KrishnaKumar V; Pichinuk E; Engel H; Raveh A; Gazit E; Segal D
Biochim Biophys Acta Gen Subj; 2018 Jul; 1862(7):1565-1575. PubMed ID: 29634991
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for inhibiting β-amyloid oligomerization by a non-coded β-breaker-substituted endomorphin analogue.
Frydman-Marom A; Convertino M; Pellarin R; Lampel A; Shaltiel-Karyo R; Segal D; Caflisch A; Shalev DE; Gazit E
ACS Chem Biol; 2011 Nov; 6(11):1265-76. PubMed ID: 21892833
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic insights into remodeled Tau-derived PHF6 peptide fibrils by Naphthoquinone-Tryptophan hybrids.
KrishnaKumar VG; Paul A; Gazit E; Segal D
Sci Rep; 2018 Jan; 8(1):71. PubMed ID: 29311706
[TBL] [Abstract][Full Text] [Related]
5. Antagonistic Activity of Naphthoquinone-Based Hybrids toward Amyloids Associated with Alzheimer's Disease and Type-2 Diabetes.
Paul A; Viswanathan GK; Mahapatra S; Balboni G; Pacifico S; Gazit E; Segal D
ACS Chem Neurosci; 2019 Aug; 10(8):3510-3520. PubMed ID: 31282646
[TBL] [Abstract][Full Text] [Related]
6. Terminal Capping of an Amyloidogenic Tau Fragment Modulates Its Fibrillation Propensity.
Arya S; Ganguly P; Arsiccio A; Claud SL; Trapp B; Schonfeld GE; Liu X; Lazar Cantrell K; Shea JE; Bowers MT
J Phys Chem B; 2020 Oct; 124(40):8772-8783. PubMed ID: 32816481
[TBL] [Abstract][Full Text] [Related]
7. Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer's disease-like symptoms in animal model.
Viswanathan GK; Shwartz D; Losev Y; Arad E; Shemesh C; Pichinuk E; Engel H; Raveh A; Jelinek R; Cooper I; Gosselet F; Gazit E; Segal D
Cell Mol Life Sci; 2020 Jul; 77(14):2795-2813. PubMed ID: 31562564
[TBL] [Abstract][Full Text] [Related]
8. Aggregation and neurotoxicity of mutant amyloid beta (A beta) peptides with proline replacement: importance of turn formation at positions 22 and 23.
Morimoto A; Irie K; Murakami K; Ohigashi H; Shindo M; Nagao M; Shimizu T; Shirasawa T
Biochem Biophys Res Commun; 2002 Jul; 295(2):306-11. PubMed ID: 12150948
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of tau amyloid formation and disruption of its preformed fibrils by Naphthoquinone-Dopamine hybrid.
Paul A; Viswanathan GK; Huber A; Arad E; Engel H; Jelinek R; Gazit E; Segal D
FEBS J; 2021 Jul; 288(14):4267-4290. PubMed ID: 33523571
[TBL] [Abstract][Full Text] [Related]
10. Effects of All-Atom Molecular Mechanics Force Fields on Amyloid Peptide Assembly: The Case of PHF6 Peptide of Tau Protein.
Man VH; He X; Gao J; Wang J
J Chem Theory Comput; 2021 Oct; 17(10):6458-6471. PubMed ID: 34491058
[TBL] [Abstract][Full Text] [Related]
11. Structural insights into the co-aggregation of Aβ and tau amyloid core peptides: Revealing potential pathological heterooligomers by simulations.
Li X; Chen Y; Yang Z; Zhang S; Wei G; Zhang L
Int J Biol Macromol; 2024 Jan; 254(Pt 2):127841. PubMed ID: 37924907
[TBL] [Abstract][Full Text] [Related]
12. Selective Inhibition of Aggregation and Toxicity of a Tau-Derived Peptide using Its Glycosylated Analogues.
Frenkel-Pinter M; Richman M; Belostozky A; Abu-Mokh A; Gazit E; Rahimipour S; Segal D
Chemistry; 2016 Apr; 22(17):5945-52. PubMed ID: 26891276
[TBL] [Abstract][Full Text] [Related]
13. Formation and growth of oligomers: a Monte Carlo study of an amyloid tau fragment.
Li DW; Mohanty S; Irbäck A; Huo S
PLoS Comput Biol; 2008 Dec; 4(12):e1000238. PubMed ID: 19057640
[TBL] [Abstract][Full Text] [Related]
14. Mirror-Image Phage Display for the Selection of D-Amino Acid Peptide Ligands as Potential Therapeutics.
Malhis M; Funke SA
Curr Protoc; 2024 Feb; 4(2):e957. PubMed ID: 38372457
[TBL] [Abstract][Full Text] [Related]
15. Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity.
Frenkel-Pinter M; Tal S; Scherzer-Attali R; Abu-Hussien M; Alyagor I; Eisenbaum T; Gazit E; Segal D
J Alzheimers Dis; 2016; 51(1):165-78. PubMed ID: 26836184
[TBL] [Abstract][Full Text] [Related]
16. Development of dual targeting inhibitors against aggregations of amyloid-β and tau protein.
Fuse S; Matsumura K; Fujita Y; Sugimoto H; Takahashi T
Eur J Med Chem; 2014 Oct; 85():228-34. PubMed ID: 25086914
[TBL] [Abstract][Full Text] [Related]
17. Modulation of fibril formation by a beta-sheet breaker peptide ligand: an electrochemical approach.
Veloso AJ; Kerman K
Bioelectrochemistry; 2012 Apr; 84():49-52. PubMed ID: 21967982
[TBL] [Abstract][Full Text] [Related]
18. Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4.
Wood SJ; Wetzel R; Martin JD; Hurle MR
Biochemistry; 1995 Jan; 34(3):724-30. PubMed ID: 7827029
[TBL] [Abstract][Full Text] [Related]
19. Primary Fibril Nucleation of Aggregation Prone Tau Fragments PHF6 and PHF6.
Smit FX; Luiken JA; Bolhuis PG
J Phys Chem B; 2017 Apr; 121(15):3250-3261. PubMed ID: 27776213
[TBL] [Abstract][Full Text] [Related]
20. The role of anionic peptide fragments in 1N4R human tau protein aggregation.
Khalili MA; Riazi G; Ahmadian S; Khodarahmi R; Khodadadi S; Afrasiabi A; Karima O; Mokhtari F; Hoveizi E
Protein Pept Lett; 2014 Jun; 21(6):511-6. PubMed ID: 24364857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
